...
首页> 外文期刊>Angewandte Chemie >Synthesis and Crystal Structure of [{nBuMg(-TMP)}2] and of a Homometallic Inverse Crown in Tetranuclear [{nBuMg_2[μ-N(H)Dipp]_2(μ_3-OnBu)}_2]
【24h】

Synthesis and Crystal Structure of [{nBuMg(-TMP)}2] and of a Homometallic Inverse Crown in Tetranuclear [{nBuMg_2[μ-N(H)Dipp]_2(μ_3-OnBu)}_2]

机译:[{nBuMg(-TMP)} 2]和四核[[nBuMg_2 [μ-N(H)Dipp] _2(μ_3-OnBu)} _ 2]的均金属反冠的合成和晶体结构

获取原文
获取原文并翻译 | 示例
           

摘要

Although the first substantial studies of organomagnesium amides "RMgN(R~1)(R~2)" took place in the 1960s through the pioneering work of Coates et al., their impact on synthesis since then has been almost invisible in comparison to that of Grignard reagents or lithium organoamides. However, recent communications by Eaton and co-workers thrusting "BuMgNiPr_2" into the limelight as a new Bronsted base for regioselective deprotonation of cyclopropane and cyclobutane carboxamides could mark a watershed in the appreciation and utilization of these hitherto largely friendless organometallics. "BuMgNiPr_2" is now sold commercially in the form of a THF solution by the chemical company Aldrich, but not as a single, well-defined compound as it contains a mixture of n-butyl and sec-butyl components.
机译:尽管通过Coates等人的开创性工作在1960年代对有机镁酰胺“ RMgN(R〜1)(R〜2)”进行了首次实质性研究,但与之相比,其对合成的影响几乎是看不到的。格氏试剂或有机锂锂。但是,伊顿公司及其同事最近的通讯将“ BuMgNiPr_2”作为一种新的布朗斯台德环丙烷和环丁烷甲酰胺区域选择性去质子化的新基地,引起了人们的关注,这可能标志着对这些迄今基本上没有朋友的有机金属的欣赏和利用。如今,“ BuMgNiPr_2”由化学公司Aldrich以THF溶液的形式商业销售,但由于含有正丁基和仲丁基成分的混合物,因此并非单一的,定义明确的化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号